Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!
EMD-70078
Plasmodium falciparum 20S proteasome bound to inhibitor 296
EMD-70078
Single-particle2.28 Å
Deposition: 07/04/2025Map released: 12/11/2025
Last modified: 26/11/2025
Sample Organism:
Plasmodium falciparum 3D7
Sample: Plasmodium falciparum 20S proteasome bound with inhibitor 296
Fitted models: 9o3f
Deposition Authors: Han Y, Deng X, Ray S, Phillips M, Phillips M
Sample: Plasmodium falciparum 20S proteasome bound with inhibitor 296
Fitted models: 9o3f
Deposition Authors: Han Y, Deng X, Ray S, Phillips M, Phillips M
Optimization of Species-Selective Reversible Proteasome Inhibitors for the Treatment of Malaria.
Gahalawat S,
Ray S,
Zhang X,
Deng X,
Han Y,
Chen Z,
Lawong A,
Shackleford DM,
Katneni K,
Chen G,
Li P,
Ng A,
Zhong L,
Hu M,
McInerney M,
Wang W,
Saunders J,
Collins D,
Jayaseelan J,
Noack CL,
C Maity B,
De N,
Laleu B,
Campbell SF,
Phillips MA,
Charman SA,
Ready JM
(2025) J Med Chem , 68 , 23485 - 23520
(2025) J Med Chem , 68 , 23485 - 23520
Grant Support:
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): R01AI103947 (United States)
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): R01AI155784 (United States)
- National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS): GM007062 (United States)
- Cancer Prevention and Research Institute of Texas (CPRIT): RP220582 (United States)
